New Drug Combats Late-stage Prostate Cancer by Angela Mohan on July 12, 2021 at 11:18 AM
New treatment combats late stage prostate cancer by delivering beta radiation directly to tumour cells. It is well tolerated by patients and keeps them alive for longer compared to standard care, as per the phase 3 trial findings.
New approach, targets a molecule called PSMA, which is known to be increased on the surfaces of the tumour cells, destroying them and their surrounding microenvironment.
International team of researchers set out to see whether Lu-PSMA-617 was more effective than standard care and recruited 831 patients with metastatic castration-resistant prostate cancer between June 2018 and October 2019. Patients were randomized to receive the treatment plus standard care or standard care alone.
Researchers Identify New Drug for Treating Childhood Cancer by Angela Mohan on February 12, 2021 at 4:02 PM
New drug combination is found to be effective in eradicating the cancer cells in incurable brain tumour named Diffuse Intrinsic Pontine Glioma (DIPG), as per the paper published in the prestigious journal,
Nature Communications by paediatric oncologist Associate Professor David Ziegler, from the Children s Cancer Institute and Sydney Children s Hospital.
In pre-clinical testing in mouse models, the researchers found that the promising drug combination led to survival in two thirds of the mice and that the drug combination completely halted growth of these highly aggressive tumours in these mice.